Siegfried Wurster

Directeur Technique/Scientifique/R&D chez Karyon-CTT Oy

Commercial Services

Consumer Services

Postes actifs de Siegfried Wurster

Sociétés	Poste	Début	Fin
Karyon-CTT Oy Karyon-CTT Oy Miscellaneous Commercial ServicesCommercial Services Karyon-CTT Oy discovers and develops novel and innovative peptide-based tumor targeting systems. Its Targeting Units (TU) are intended for delivery of diagnostic imaging agents or therapeutic compounds to cancer tissue. The company was founded in 2006 and is headquartered in Helsinki, Finland.	Directeur Technique/Scientifique/R&D	01/01/2006	-

Sociétés	Poste	Début	Fin
Juvantia Pharma Oy Juvantia Pharma Oy Miscellaneous Commercial ServicesCommercial Services Juvantia Pharma Oy discovers and develops pharmaceuticals and drugs. The firm develops products for the treatment of Parkinson's disease, depression and schizophrenia, vasoconstrictive disorders, fibro proliferative vasculopathies and chronic pain.The company was founded by Risto Arvo Sakari Lammintausta in 1997 and is headquartered in Turku, Finland.	Directeur Technique/Scientifique/R&D	-	-

University of Freiburg

Doctorate Degree

Internationale

Finlande	3
Allemagne	2

Opérationnelle

Chief Tech/Sci/R&D Officer	2
Doctorate Degree	1

Sectorielle

Commercial Services	3
Consumer Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Entreprise privées	2
Juvantia Pharma Oy Juvantia Pharma Oy Miscellaneous Commercial ServicesCommercial Services Juvantia Pharma Oy discovers and develops pharmaceuticals and drugs. The firm develops products for the treatment of Parkinson's disease, depression and schizophrenia, vasoconstrictive disorders, fibro proliferative vasculopathies and chronic pain.The company was founded by Risto Arvo Sakari Lammintausta in 1997 and is headquartered in Turku, Finland.	Commercial Services
Karyon-CTT Oy Karyon-CTT Oy Miscellaneous Commercial ServicesCommercial Services Karyon-CTT Oy discovers and develops novel and innovative peptide-based tumor targeting systems. Its Targeting Units (TU) are intended for delivery of diagnostic imaging agents or therapeutic compounds to cancer tissue. The company was founded in 2006 and is headquartered in Helsinki, Finland.	Commercial Services

Entreprise privées

Commercial Services